- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02723565
Ultrasound to Evaluate Failure of Liberation From Mechanical Ventilation (USEFUL)
26. marts 2019 opdateret af: Ewan Goligher, University Health Network, Toronto
This study will evaluate the heart, lungs and diaphragm of patients who fail a trial of spontaneous breathing to determine the physiological mechanism of weaning failure.
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
The transition to unassisted breathing after invasive ventilation often proves challenging, with over 40% of patients failing their first attempt of unassisted breathing.
Persistent ventilator dependence predisposes patients to nosocomial complications and increases the economic burden of critical illness.
Ventilator-dependence results from an imbalance between the load and capacity of the respiratory muscle pump.
Patients who fail a trial of spontaneous breathing commonly exhibit excess respiratory loads secondary to weaning-induced pulmonary edema, atelectasis or dynamic hyperinflation.
Many patients who are dependent on the ventilator also show a striking loss of pump capacity due to diaphragm dysfunction.
Though each of these mechanisms respond to specific interventions, it is often difficult for physicians to discern which mechanisms are at play at the bedside.
Bedside ultrasound is a potentially useful means of evaluating cardiac, pulmonary and diaphragm function during weaning failure.
It is readily available, highly feasible and already widely employed in clinical practice.
As yet, no study has evaluated the accuracy and feasibility of combining echocardiography with lung and diaphragm ultrasound to comprehensively evaluate the physiological mechanisms of weaning failure.
The objectives of this study are to establish the utility of a rapid thoracic ultrasound exam to diagnose mechanisms of ventilation liberation failure and to assess the relationship between cardiothoracic variability during spontaneous breathing and different physiological mechanism of weaning failure.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
7
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael's Hospital
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M5G 2N2
- University Health Network
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Patients in the intensive care unit.
Beskrivelse
Inclusion Criteria:
- patients over 18 years of age receiving invasive mechanical ventilation for at least 24 hours
- patients who fulfill standard criteria for readiness for a trial of spontaneous breathing (no or minimal sedation, patient awake and interactive; minimal vasopressor/inotrope requirements (Norepinephrine < or = 0.1, Dopamine < 10, Vasopressin/Epinephrine off); fraction of inspired oxygen < or = 50%; spontaneous inspiratory efforts as indicated by patient-triggered breaths; positive end-expiratory pressure < or = 10 cm H20)
- patients who fail a trial of spontaneous breathing (transient reduction of ventilator support for any duration up to 2 hours as per local ICU practice - typically PS 5 with PEEP 5 OR CPAP 5 OR T-piece)
Exclusion Criteria:
- patients with a coagulopathy (INR > 2.5, platelet count < 30x10^6/L) or previously diagnosed bleeding diathesis or are receiving anticoagulant drugs at therapeutic doses (ie. excluding venous thromboembolic prophylaxis)
- patients with a contraindication to nasogastric tube insertion (esophageal varices, upper GI tract surgery, facial trauma, etc.)
- patients receiving extra-corporeal life support
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Sensitivity and specificity for diagnosis of physiological mechanisms causing weaning failure
Tidsramme: Physiological measurements for diagnostic classification measured simultaneously with ultrasound measurements
|
Mechanisms responsible for weaning failure will be diagnosed by field experts using clinical data collected from the chart along with physiological measurements (respiratory mechanics, maximal inspiratory pressure, markers of pulmonary edema including changes in serum total protein and BNP and central venous pressure).
The diagnosis derived from a pre-specified ultrasound-based classification system will be compared to the gold standard expert-derived diagnosis.
|
Physiological measurements for diagnostic classification measured simultaneously with ultrasound measurements
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. april 2014
Primær færdiggørelse (Faktiske)
1. december 2018
Studieafslutning (Faktiske)
1. december 2018
Datoer for studieregistrering
Først indsendt
24. marts 2016
Først indsendt, der opfyldte QC-kriterier
24. marts 2016
Først opslået (Skøn)
30. marts 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
28. marts 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
26. marts 2019
Sidst verificeret
1. marts 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 14-7400-B
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Akut respirationssvigt
-
Hospices Civils de LyonAfsluttetAkut Respiratory Distress Syndrome (ARDS)Frankrig
-
Aqualung Therapeutics Corp.Ikke rekrutterer endnuAkut Respiratory Distress Syndrome (ARDS)
-
Unity Health TorontoRekrutteringAkut Respiratory Distress Syndrome (ARDS)Canada, Spanien, Italien, Brasilien
-
Hospices Civils de LyonAfsluttetAkut Respiratory Distress Syndrome (ARDS)Frankrig
-
European Society of Intensive Care MedicineAfsluttetModerat Akut Respiratory Distress SyndromeBelgien
-
Policlinico HospitalAfsluttetAkut Respiratory Distress Syndrome (ARDS)Italien
-
Gamaleya Research Institute of Epidemiology and...Ikke rekrutterer endnuAkut Respiratory Distress Syndrome (ARDS)
-
Centre Hospitalier Universitaire DijonRekrutteringFocal Acute Respiratory Distress SyndromeFrankrig
-
Hospices Civils de LyonAfsluttetAkut Respiratory Distress Syndrome (ARDS)Frankrig
-
The Second Affiliated Hospital of Chongqing Medical...Children's Hospital of Chongqing Medical University; Chongqing Medical... og andre samarbejdspartnereIkke rekrutterer endnuAcute respiratory distress syndrom | Respiratory Distress Syndrome, Akut